Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

Abbreviated New Drug Application (ANDA): 076753
Company: TARO
Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status TE Code RLD RS
BETAMETHASONE DIPROPIONATE BETAMETHASONE DIPROPIONATE EQ 0.05% BASE OINTMENT, AUGMENTED;TOPICAL Prescription AB No No
Original Approvals or Tentative Approvals
Action Date Submission Action Type Submission Classification Review Priority; Orphan Status Letters, Reviews, Labels, Patient Package Insert Notes Url
10/12/2004 ORIG-1 Approval

Label is not available on this site.

Supplements
Action Date Submission Supplement Categories or Approval Type Letters, Reviews, Labels, Patient Package Insert Note Url
06/11/2020 SUPPL-9 Labeling-Package Insert

Label is not available on this site.

06/04/2015 SUPPL-7 Labeling-Package Insert

Label is not available on this site.

BETAMETHASONE DIPROPIONATE

OINTMENT, AUGMENTED;TOPICAL; EQ 0.05% BASE
TE Code = AB

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status RLD TE Code Application No. Company
BETAMETHASONE DIPROPIONATE BETAMETHASONE DIPROPIONATE EQ 0.05% BASE OINTMENT, AUGMENTED;TOPICAL Prescription No AB 074304 ACTAVIS MID ATLANTIC
BETAMETHASONE DIPROPIONATE BETAMETHASONE DIPROPIONATE EQ 0.05% BASE OINTMENT, AUGMENTED;TOPICAL Prescription No AB 075373 FOUGERA PHARMS
BETAMETHASONE DIPROPIONATE BETAMETHASONE DIPROPIONATE EQ 0.05% BASE OINTMENT, AUGMENTED;TOPICAL Prescription No AB 209106 LUPIN LTD
BETAMETHASONE DIPROPIONATE BETAMETHASONE DIPROPIONATE EQ 0.05% BASE OINTMENT, AUGMENTED;TOPICAL Prescription No AB 076753 TARO
BETAMETHASONE DIPROPIONATE BETAMETHASONE DIPROPIONATE EQ 0.05% BASE OINTMENT, AUGMENTED;TOPICAL Prescription No AB 206118 TELIGENT
DIPROLENE BETAMETHASONE DIPROPIONATE EQ 0.05% BASE OINTMENT, AUGMENTED;TOPICAL Prescription Yes AB 018741 MERCK SHARP DOHME

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English